HealthTree Logo
search more_vert
person Sign In / Create Account
Patient Power: Monoclonal Antibodies in Myeloma
Posted: Nov 22, 2017
Patient Power: Monoclonal Antibodies in Myeloma image

Monoclonal antibodies have now been in use in the myeloma clinic since November of 2015. Dr. Gareth Morgan of the University of Arkansas Medical Sciences (UAMS) Myeloma Institute shares how they work and where the field is headed. He mentions the development of bi-specific antibodies, which are new drugs that can link an immune cell with the target on the surface of myeloma cells for greater specificity and impact. Learn more about this new class of drugs in this recent show on Myeloma Crowd Radio.

What Do Monoclonal Antibodies Do in Myeloma? from Patient Power on Vimeo.

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of HealthTree Foundation (formerly Myeloma Crowd). 

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook twitter